In 2008, an AACR Centennial Postdoctoral Fellowship Award enabled Heiko Enderling, PhD, to build a mathematical model that could explain some of the dynamics of cancer stem cells. This research yielded several other papers and helped Dr. Enderling compete for a position at Moffitt Cancer Center, where he currently serves as an Associate Professor, Integrated Mathematical Oncology, Radiation Oncology.
In 2003, Patrick Ma, MD, received the AACR-AstraZeneca-Cancer Research and Prevention Foundation fellowship and used it to study c-Met mutations in lung cancer and the therapeutic potential of targeting c-Met. He's now leader of the multidisciplinary thoracic oncology disease team at the Penn State Cancer Institute. Read how the AACR fellowship helped launch his career.
A post-doctoral fellow at the Olivia Newton-John Cancer Research Institute, Australia, Ashleigh Poh, PhD, received one of the gastric cancer research fellowships given in 2018. She set out to investigate the role of hematopoietic Cell Kinase (HCK) in gastric cancer. Dr. Poh shared how her AACR fellowship made an impact on her research and career.
The Breast Cancer Research Foundation-AACR Career Development Awards for Translational Breast Cancer Research support innovative breast cancer-focused research. 2018 recipient Camila dos Santos, PhD, shared how her career development award made an impact on her research and career.
The AACR-Bayer START grant gives early career investigators the unique opportunity to gain experience not only in academic but also in industry settings. Mark Labrecque, PhD, speaks on the impact of this grant on his career and research.
Glioblastoma is an aggressive form of brain cancer. Less than 5 percent of patients diagnosed with this cancer type will survive for five years or more. Glioblastoma is notoriously difficult to treat, and new avenues for diagnosis and treatment are...
AACR grantee Yi Fan, PhD, shared how flexible funding from an AACR Judah Folkman Career Development Award allowed him to explore an unconventional angle of anti-vascular therapy; namely, targeting genetic endothelial transformation, to fight the deadliest of brain cancers.
When Matthew Vander Heiden was working on his MD/PhD, trying to understand how apoptotic cell death is regulated by bcl-2 proteins located at the mitochondrial outer membrane, it occurred to him he would have to go back to basics.
Growing up in Australia, Charles Mullighan knew he wanted to be a doctor but never thought about working in Memphis, Tennessee. But that is exactly where he ended up, at a hospital named for the patron saint of impossible causes.
With a little help from the AACR, a fascination with cancer-associated viruses has turned into a successful career in research for Blossom Damania, PhD, of the University of North Carolina at Chapel Hill – a career that has gone global with research projects on four continents.